Following review of data from the phase 2 ARTISTRY-6 trial and previously announced results from the phase 3 ARTISTRY-7 trial, Mural will discontinue all clinical development of nemvaleukin With $144.

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

How would you summarize your study for a lay audience?Research on gastrointestinal diseases, especially cancer, has mainly looked at the epithelial ...

Hypochlorous acid is safe enough to spray in your eyes yet more effective than bleach. Why isn’t it everywhere?

The Davao City Health Office on Friday confirmed that the city logged two monkeypox (mpox) cases last Wednesday, April 16. In ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an ...

Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology: Uppsala, Sweden Saturday, April 12, 2025, 13:00 Hrs [IST] Orexo AB (publ ...

Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare, indolent subtype of non-Hodgkin lymphoma ...

There’s no way to completely avoid microplastics. The good news is that there are steps you can take to reduce your ...

The City Government of Davao has confirmed that the city has recorded two cases of monkeypox (mpox) and one of the patients ...